Status:
RECRUITING
Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit
Lead Sponsor:
Meir Medical Center
Conditions:
Thyroid; Functional Disturbance
Eligibility:
All Genders
18-99 years
Brief Summary
Nonthyroidal illness (formerly called sick euthyroid syndrome) is a common condition in patients hospitalized in the intensive care unit, and it is caused by changes in the levels of thyroid hormones ...
Eligibility Criteria
Inclusion
- All patients aged 18--99 who were admitted to the general intensive care unit from January 2016 to November 22, 2023 for any reason, and who during their hospitalization in the intensive care unit had lower than normal T4 levels measured. It is about 350 patients. Of these, we will specifically examine the group of patients for whom an extremely low level of T4 was measured (less than 50% of the lower limit of the norm).
- \-
Exclusion
- Patients who were known to have a chronic thyroid dysfunction prior to their hospitalization in the unit, patients who were regularly treated with eltroxin prior to their hospitalization
- \-
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06154382
Start Date
June 1 2024
End Date
February 1 2026
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel